| First Author | Sumioka T | Year | 2013 |
| Journal | Lab Invest | Volume | 93 |
| Issue | 2 | Pages | 207-17 |
| PubMed ID | 23207449 | Mgi Jnum | J:192562 |
| Mgi Id | MGI:5465378 | Doi | 10.1038/labinvest.2012.157 |
| Citation | Sumioka T, et al. (2013) Impaired cornea wound healing in a tenascin C-deficient mouse model. Lab Invest 93(2):207-17 |
| abstractText | We investigated the effects of loss of tenascin C on the healing of the stroma using incision-injured mice corneas. Tenascin C was upregulated in the stroma following incision injury to the cornea. Wild-type (WT) and tenascin C-null (knockout (KO)) mice on a C57BL/6 background were used. Cell culture experiments were also conducted to determine the effects of the lack of tenascin C on fibrogenic gene expression in ocular fibroblasts. Histology, immunohistochemistry and real-time reverse transcription PCR were employed to evaluate the healing process in the stroma. The difference in the incidence of wound closure was statistically analyzed in hematoxylin and eosin-stained samples between WT and KO mice in addition to qualitative observation. Healing of incision injury in corneal stroma was delayed, with less appearance of myofibroblasts, less invasion of macrophages and reduction in expression of collagen Ialpha1, fibronectin and transforming growth factor beta1 (TGFbeta1) in KO mice compared with WT mice. In vitro experiments showed that the loss of tenascin C counteracted TGFbeta1 acceleration of mRNA expression of TGFbeta1, and of collagen Ialpha1 and of myofibroblast conversion in ocular fibroblasts. These results indicate that tenascin C modulates wound healing-related fibrogenic gene expression in ocular fibroblasts and is required for primary healing of the corneal stroma. |
